Retatrutide
Retatrutide is a synthetic triple agonist that activates the GLP-1, GIP, and glucagon receptors simultaneously, making it the broadest-acting compound currently studied in the incretin research class.
Research Applications
- Body weight and adiposity regulation in preclinical metabolic models
- Combined incretin and glucagon receptor signalling studies
- Comparative research against dual-agonist and single-agonist GLP-1 compounds
Compound Information
Triple GLP-1/GIP/glucagon receptor agonist. Supplied as lyophilised powder for reconstitution.
Technical Specifications
- Molecular Formula: C221H342N46O68
- Molecular Weight: 4731.33 g/mol
- Sequence: 39-residue modified peptide (GIP-backbone triple agonist)
- CAS Number: 2381089-83-2
For laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement, and not evaluated by the MHRA or any regulatory body for safety or efficacy. Buyers are responsible for ensuring their use complies with applicable laws and regulations.